Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Birkmayer

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Acta Vitaminologica Et Enzymologica|January 1, 1975
On the determination of free L-tryptophanP Riederer, E Bamberg, W Birkmayer
MMW, Munchener Medizinische Wochenschrift|May 30, 1975
Proceedings; Biochemistry of circadian rhythm in endogenous depressionW Birkmayer, E Neumayer, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1983
Symptoms and side effects in the course of Parkinson's diseaseW Birkmayer, W Danielczyk, P Riederer
Journal of Neural Transmission|January 1, 1973
The tyrosine-tryptophan-diagram in a longtime study with depressed patientsP Riederer, W Birkmayer, E Neumayer
Clinical Neurology and Neurosurgery|January 1, 1979
Distinction between benign and malignant type of Parkinson's diseaseW Birkmayer, P Riederer, B H Youdim
Clinical Neuropharmacology|January 1, 1982
(-)Deprenyl in the treatment of Parkinson's diseaseW Birkmayer, P Riederer, M B Youdim
Journal of Neural Transmission|January 1, 1977
Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndromeP Riederer, W Birkmayer, D Seemann, et al.
Wiener Medizinische Wochenschrift (1946)|June 1, 1974
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)]W Birkmayer, W Linauer, M Mentasti, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1980
4-hydroxy-3-methoxyphenylglycol as an index of brain noradrenaline turnover in endogenous depressionP Riederer, W Birkmayer, D Seemann, et al.
Journal of Neural Transmission|January 1, 1972
The balance of biogenic amines as condition for normal behaviourW Birkmayer, W Danielczyk, E Neumayer, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Acta Vitaminologica Et Enzymologica|January 1, 1975
On the determination of free L-tryptophanP Riederer, E Bamberg, W Birkmayer
MMW, Munchener Medizinische Wochenschrift|May 30, 1975
Proceedings; Biochemistry of circadian rhythm in endogenous depressionW Birkmayer, E Neumayer, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1983
Symptoms and side effects in the course of Parkinson's diseaseW Birkmayer, W Danielczyk, P Riederer
Journal of Neural Transmission|January 1, 1973
The tyrosine-tryptophan-diagram in a longtime study with depressed patientsP Riederer, W Birkmayer, E Neumayer
Clinical Neurology and Neurosurgery|January 1, 1979
Distinction between benign and malignant type of Parkinson's diseaseW Birkmayer, P Riederer, B H Youdim
Clinical Neuropharmacology|January 1, 1982
(-)Deprenyl in the treatment of Parkinson's diseaseW Birkmayer, P Riederer, M B Youdim
Journal of Neural Transmission|January 1, 1977
Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndromeP Riederer, W Birkmayer, D Seemann, et al.
Wiener Medizinische Wochenschrift (1946)|June 1, 1974
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)]W Birkmayer, W Linauer, M Mentasti, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1980
4-hydroxy-3-methoxyphenylglycol as an index of brain noradrenaline turnover in endogenous depressionP Riederer, W Birkmayer, D Seemann, et al.
Journal of Neural Transmission|January 1, 1972
The balance of biogenic amines as condition for normal behaviourW Birkmayer, W Danielczyk, E Neumayer, et al.
Pageof 8